Inflammatory biomarkers in depression: scoping review
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Inflammation is increasingly recognised as a fundamental component of the pathophysiology of major depressive disorder (MDD), with a variety of inflammatory biomarkers playing pivotal roles. These markers are closely linked to both the severity of symptoms and the responsiveness to treatments in MDD. Aims: This scoping review aims to explore the scientific literature investigating the complex relationships between inflammatory biomarkers and depression, by identifying new studies and critical issues in current research. Method: Following the PRISMA Extension for Scoping Reviews guidelines, we systematically searched databases including PubMed, Scopus, PsycINFO, Open Grey and Cochrane Library. Our search focused on articles published from 1 January 2020 to 1 May 2024. We included studies evaluating inflammatory biomarkers in adult patients with MDD, utilising observational and randomised controlled trial designs, and review studies. Results: Our analysis examined 44 studies on the complex interplay between inflammation and its multiple effects on MDD. Significant associations between specific inflammatory biomarkers and depression severity were found, requiring cautious interpretation. We also highlight several methodological limitations in the current studies, which warrant caution in directly applying these findings to clinical practice. However, identified methodologies show potential for using these biomarkers as diagnostic tools or therapeutic targets, including anti-inflammatory interventions. Conclusions: The findings emphasise the need for sophisticated, integrative research to understand inflammation's role in MDD. Future studies should identify specific biomarker panels for diagnosing depression and bridging peripheral biomarker measurements with central neuroinflammatory processes, leading to better diagnostic and treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“some data suggest that elevated inflammatory markers may predict a better response to dopaminergic versus serotonergic agents, consistent with the preferential effects of inflammatory mediators on mesolimbic dopamine circuits [60].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444 · cited 1×
“2 Recent research has emphasised the role of biological markers in indicating the presence and severity of MDD. 3 – 7 Over 9000 studies have investigated the immune system ’ s role in depression, and particularly how inflammation contributes to MDD. 8 The relationship was initially linked to…”
BackgroundOtte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170 · cited 1×
“40 Although increased inflammatory cytokines are observed in some patients with depression, this does not necessarily indicate that inflammation is a universal aspect of the disorder.”
BackgroundStrimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Holt-Lunstad, J. (2018) · Annual Review of Psychology · doi:10.1146/annurev-psych-122216-011902 · Cited by 873 · cited 1×
“28 Attention to pro-inflammatory cytokines has led to their consideration in screening and predicting responses to antidepressant treatment.”
BackgroundIntegrating neuroimmune systems in the neurobiology of depression
Wohleb, E. S., Franklin, T., Iwata, M., & Duman, R. S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.69 · Cited by 668 · cited 1×
“29 For example, elevated levels of circulating inflammatory markers predict a poor response to selective serotonin reuptake inhibitors, whereas high levels of these markers predict an enhanced response to tricyclic antidepressants, ketamine and electroconvulsive therapy.”
Background
Research works printed but not linked: 60
- 10.1016/j.neubiorev.2009.12.012 · DOI · Paper page
- 10.1017/S204579601500089X · DOI · Paper page
- 10.1177/0963721412463229 · DOI
- 10.1176/appi.ajp.2021.20121776 · DOI · Paper page
- 10.1016/j.bbi.2020.11.024 · DOI
- Baune, 2018, Inflammation and Immunity in Depression: Basic Science and Clinical Applications
- 10.1016/j.neuron.2020.06.002 · DOI · Paper page
- 2015, Translational Regenerative Medicine
- 10.1016/j.euroneuro.2023.09.006 · DOI
- 10.1016/B978-0-12-804217-5.00019-9 · doi:10.1016/b978-0-12-804217-5.00019-9
- 10.1038/s41380-019-0474-5 · DOI · Paper page
- 10.3390/ijms24010578 · DOI · Paper page
- 10.1016/j.euroneuro.2021.11.003 · DOI
- 10.1016/j.jad.2022.06.073 · DOI
- 10.1016/j.jad.2024.02.078 · DOI
- 10.1016/j.psyneuen.2024.107008 · DOI
- 10.1038/s41598-024-51932-9 · DOI
- 10.1101/cshperspect.a016303 · DOI · Paper page
- Mandal, 2023, Inflammatory markers in patients with major depressive disorder: a prospective, clinic-based, cohort study from India, Cureus, 15, e43059
- 10.1177/02698811211026426 · DOI · Paper page
- 10.1016/j.psychres.2023.115671 · DOI
- 10.3390/ijms24010578 · DOI · Paper page
- 10.1037/abn0000716 · DOI
- 10.1016/j.bbi.2022.12.014 · DOI
- 10.1016/j.jpsychires.2023.01.012 · DOI
- 10.1159/000350094 · DOI · Paper page
- 10.1016/j.jad.2020.12.109 · DOI
- 10.1016/j.jad.2021.10.042 · DOI
- 10.1016/j.jpsychires.2022.12.009 · DOI
- 10.1016/j.neubiorev.2023.105425 · DOI
- 10.1016/j.pnpbp.2023.110931 · DOI
- 10.1080/08039488.2023.2274341 · DOI
- 10.1016/j.pnpbp.2022.110674 · DOI
- 10.1016/j.pnpbp.2020.110151 · DOI
- 10.1017/neu.2019.19 · DOI
- 10.1136/gpsych-2022-100844 · DOI
- 10.1038/s41380-023-01976-6 · DOI
- 10.3389/fpsyt.2023.1184188 · DOI
- 10.1016/j.pnpbp.2021.110343 · DOI
- 10.1111/ejn.15992 · DOI
- 10.2174/2666082219666221114114738 · DOI
- 10.1016/j.brainresrev.2010.09.008 · DOI
- 10.1016/j.cpcardiol.2023.102352 · DOI
- Gasparini, 2022, Inflammatory biomarker and response to antidepressant in major depressive disorder: a systematic review and meta-analysis, Psychopharmacol Bull, 52, 36
- 10.1016/j.pnpbp.2020.110136 · DOI · Paper page
- 10.1016/j.jad.2021.03.036 · DOI
- 10.1016/j.jad.2017.09.052 · DOI · Paper page
- 10.1067/mcp.2001.113989 · DOI · Paper page
- 10.1016/j.bbi.2019.09.016 · DOI · Paper page
- 10.1038/s41398-022-01918-w · DOI
- 10.1016/j.eclinm.2021.100992 · DOI · Paper page
- 10.3390/ijms232415460 · DOI
- 10.1016/j.bbi.2021.07.007 · DOI
- 10.1038/s41598-020-66532-6 · DOI · Paper page
- 10.1016/j.bbi.2021.03.024 · DOI
- 10.1016/j.euroneuro.2021.09.006 · DOI · Paper page
- Sompayrac, 2008, How the Immune System Works
- 10.1056/NEJM200003233421202 · DOI · Paper page
- 10.1016/j.copsyc.2018.03.012 · DOI
- 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
Cited by
Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
“Previously published evidence emphasizes the need for sophisticated, integrative research to understand inflammation’s role in MDD [16].”
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Paganin, W., & Signorini, S.
- Venue
- BJPsych Open
- Publisher
- Royal College of Psychiatrists
- Published
- 2024-09
- Volume
- 10
- Issue
- 5
- ISSN
- 2056-4724
- Cited by
- 57
- References
- 24
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory biomarkers in depression: scoping review. https://app.cochat.ai/papers/10.1192/bjo.2024.787
- The paper
- Paganin, W., & Signorini, S. (2024). Inflammatory biomarkers in depression: scoping review. BJPsych Open. https://doi.org/10.1192/bjo.2024.787
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.